Competition in the drug market: Safe again?

(June 15, 2011) -- Two pharmaceutical companies that have waited patiently to complete their $3.4 billion deal may proceed under strict conditions, though one Commissioner has questioned the ultimate effectiveness of the consent order....

Related Sections